Navigation Links
Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
Date:6/12/2012

THOUSAND OAKS, Calif., June 12, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat Pharmaceuticals, a privately held Turkish company. The all-cash transaction significantly expands Amgen's presence in Turkey and the surrounding region, which includes several fast-growing, priority markets for Amgen. The acquisition was initially announced on April 25.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.

Forward-Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2011, and in our periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guarante
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
8. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
9. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
10. CryoLife Completes Acquisition of Hemosphere
11. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15, 2014 /PRNewswire/ -  Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... company with a focus on Omega-3 therapies for ... the Board of Directors approved the granting of ... the close of business on Friday, September 12, ... common shares of the Company were granted in ...
(Date:9/15/2014)... 15, 2014 /PRNewswire-iReach/ -- "Spain Aesthetic Lasers and ... market data on the Spain Aesthetic Lasers and ... millions of US dollars, volume (in units) and ... Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices ... Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted ...
(Date:9/15/2014)... /PRNewswire-iReach/ -- On September 8, 2014, Dr. ... a Citizen Petition to Dr. Margaret Hamburg ... another Black Box Warning to Levaquin, Cipro, and ... a Black Box Warning for the following psychiatric ... or acts, loss of consciousness, delirium, depressed level ...
Breaking Medicine Technology:Pivotal Therapeutics Grants Incentive Stock Options 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 2Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 3
... Reportlinker.com announces that a new ... its catalogue: Epidemiology: ... risk factor for deep vein thrombosis ... http://www.reportlinker.com/p0536561/Epidemiology-Major-Abdominal-Surgery-–-A-key-risk-factor-for-deep-vein-thrombosis-and-pulmonary-embolism.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory ...
... 2011 Zimmer Holdings, Inc. (NYSE and SIX: ZMH), ... will be participating in the Goldman Sachs 32nd Annual ... Palos Verdes, California, on June 7, 2011, at 8:40 ... of the presentation can be accessed via Zimmer,s Investor ...
Cached Medicine Technology:Reportlinker Adds Epidemiology: Major Abdominal Surgery - A key risk factor for deep vein thrombosis and pulmonary embolism 2Zimmer Holdings to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference 2
(Date:9/15/2014)... Sept. 15, 2014 (HealthDay News) -- U.S. heart experts ... electrocardiogram (ECG) when evaluating young people for underlying heart ... The American Heart Association and the American College of ... detailed personal and family medical history along with a ... or congenital (existing from birth) risks for sudden cardiac ...
(Date:9/15/2014)... September 12, 2014 - An estimated 8% of ... at some point during their lifetime. Brought on by ... the result of altered chemistry and physiology of the ... brain versus one altered by PTSD is essential to ... Center for BrainHealth at The University of Texas at ...
(Date:9/15/2014)... September 15, 2014 This year, ... founding in 2007. To mark the special occasion, Avenidas ... supporting the village and helping it to get started ... secure and fun community for seniors. Members of Avenidas ... and live in their own homes. They are able ...
(Date:9/15/2014)... Amy Norton HealthDay Reporter ... small number of medications are responsible for sending thousands of ... government study finds. Each year between 2007 and 2011, ... after getting a hold of family members, medication, according to ... "Three-quarters of those children were just 1 or 2 years ...
(Date:9/15/2014)... 15, 2014 Array Health ... technology, today announced that Independence Blue Cross ... southeastern Pennsylvania, has selected the Array Spectrum™ Private ... exchange marketplace for employers with more than 100 ... Spectrum™, Independence will offer employer groups a comprehensive ...
Breaking Medicine News(10 mins):Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:EEG study findings reveal how fear is processed in the brain 2Health News:Avenidas Village Celebrates Anniversary 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 3Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 2Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 3
... comes to chronic disease care, study finds , , TUESDAY, ... factor driving soaring rates of chronic disease in the ... their European counterparts, a new study finds. , It,s ... such as diabetes and heart disease account for some ...
... October 1, 2007 -- According to a study conducted ... lesbian, gay, and bisexual populations, blacks and Latinos do ... on the theory that stress related to prejudice would ... black lesbians, gay men, and bisexuals face prejudice related ...
... treatments can be the worst news a cancer patient ... of Missouri-Columbia is working steadfastly to learn why some ... drug cisplatin, in hopes of identifying the particular genes ... as possible. , In a paper published in the ...
... The first significant genetic finding in premenstrual dysphoric ... a very severe form of the more commonly known ... 5-8% of women, and is associated with severe emotional ... anger, headaches, weight gain and more, to such an ...
... When an adult suffers a cardiorespiratory arrest the rapid ... avoid sudden death in many cases. Nevertheless, defibrillation also ... that passes from the moment of the attack, the ... in order to avoid avoidable deaths, more and more ...
... N.J., Oct. 2 MedQuist Inc.,(Pink Sheets: ... multi-year agreement,with MedAssets Supply Chain Systems, one ... the relationship with MedAssets and,allowing them to ... speech,recognition and clinical documentation solutions. As ...
Cached Medicine News:Health News:Obesity Driving Rising U.S. Health Costs 2Health News:Obesity Driving Rising U.S. Health Costs 3Health News:Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study 2Health News:MU researchers studying model to learn why certain cancers become resistant to drugs 2Health News:First significant genetic finding in severe PMS, or PMDD 2Health News:Algorithms to reanimate the heart 2Health News:Algorithms to reanimate the heart 3Health News:MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions 2Health News:MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions 3
Acuvue Toric is an exceptionally comfortable soft contact lens made especially for people with astigmatism. The Acuvue Toric lens is designed to comfortably fit the unique shape of your eye....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
Easyloupes are exceptional optics that you have come to expect from Oculus. Available in either 1.8x or 2.5x magnification and 40 cm working distance (15.75 inches), they have the well-known durabili...
... designed for computer operators who require ... placed at different heights and distanced ... Card is printed two sided- black ... and uses two type sizes to ...
Medicine Products: